Denintuzumab (Anti-CD19)

Denintuzumab (anti-CD19) is a recombinant humanized anti-CD19 monoclonal antibody that can be used in the research of acute lymphoblastic leukemia. Denintuzumab can be used to synthesize ADC antibody Denintuzumab Mafodotin (SGN-CD19A). MW: 145.0 kD.

• Supplier: Selleck Chemicals
• Product #: A2795
• Sku #: A2795-1mg